nVerses Capital, LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 2011399 WELLINGTON, FL

Position in CRL

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$224,748

New position

Shares Held

991

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#394

of 564 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

nVerses Capital, LLC holds $800,339 across 3 Diagnostics & Research names. CRL ranks #3 (28.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TWST	Twist Bioscience Corp	3,132	$322,220
2	ILMN	Illumina, Inc.	1,441	$253,371
3	CRL	Charles River Laboratories International, Inc. This page	991	$224,748

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$224,748	991	—	Shares	Sole	2026-08-04
No filing history on record for this holder in this stock.